stock-detail (AZN)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

Supercomputers to Play a Key Role In Supporting Biden's Cancer Effort

6/16/2016 12:00 pm

(STAT) June 15, 2016 - The Department of Energy says it may have found a fast way to find new tactics for treating cancer: Supercomputers.

Exact Sciences' Cologuard Included in Final USPSTF Colorectal Cancer Screening Recommendations

6/16/2016 11:03 am

(Exact Sciences) June 15, 2016 - Exact Sciences Corp. today announced that the U.S. Preventive Services Task Force (USPSTF) issued its final 2016 colorectal cancer screening recommendations and clarified the inclusion of Cologuard® (FIT-DNA) on equal standing among the other included screening tests.

Impotence Drugs Won't Raise Melanoma Risk, Study Suggests

6/15/2016 11:05 am

(U.S. News & World Report/HealthDay News) June 14, 2016 - Three widely used erectile dysfunction drugs -- Cialis, Levitra and Viagra -- aren't likely to boost the risk of melanoma skin cancer, a new study reports.

Scientists Work To Protect The Kidneys From Powerful Cancer Drug

6/15/2016 11:05 am

(Jagwire/Augusta University) June 13, 2016 - Researchers want to turn the tide by protecting the kidneys while improving cisplatin’s efficacy against cancer.

Elderly Patients With Glioblastoma Live Longer With Chemoradiation Using Temozolomide

6/5/2016 06:00 pm

(2016 ASCO Annual Meeting) June 5, 2016 – A Canadian-led randomized phase III trial found that adding temozolomide (Temodar) chemotherapy during short-course radiation therapy, followed by monthly maintenance doses of temozolomide, significantly improved survival of elderly patients with glioblastoma, reducing the risk of death by 33%.

Double Stem-Cell Transplant Improves Outcomes for Children with High-Risk Neuroblastoma

6/5/2016 06:00 pm

(2016 ASCO Annual Meeting) June 5, 2016 – A National Cancer Institute (NCI) funded phase III trial performed by the Children's Oncology Group found that adding a second autologous stem-cell transplant (ASCT, a transplant that uses the patient's own stem cells) to standard therapy improves outcomes for patients.

Breast Cancer Study Shows Benefit To Extended Treatment With Aromatase Inhibitors

6/5/2016 05:05 pm

(STAT/In the Lab) June 5, 2016 - Older women being treated for the most common form of breast cancer who took drugs called aromatase inhibitors for 10 years rather than the usual five had a lower risk of their cancer returning, particularly in the opposite breast, physicians reported Sunday at the annual meeting of the American Society of Clinical Oncology.

Oncology Value Framework Moves Toward Test

6/3/2016 01:03 pm

(MedPage Today) June 2, 2016 - Development of a software tool to aid cancer therapy decision making will continue toward a pilot study by the end of the year, following tweaking in response to feedback on a draft proposal.

Two-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer Patients, Moffitt Study Shows

6/2/2016 11:03 am

(Moffitt Cancer Center) June 2, 2016 - Small cell lung cancer represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond to initial chemotherapy; however, they eventually relapse and develop progressive disease that has no effective treatment options.

Relypsa Scores Big Win When Pharma Rival Flops at FDA

5/27/2016 10:03 am

(TheStreet.com) May 27, 2016 - FDA rejects AstraZeneca's potassium-lowering drug, which means Relypsa's competing drug, already approved, has the commercial market all to itself.

Amgen Highlights Data To Be Presented At 21st Congress Of The European Hematology Association

5/20/2016 11:04 am

(Benzinga) May 19, 2016 - BLINCYTO® (blinatumomab) TOWER study demonstrates improved overall survival versus standard of care in patients with B-Cell precursor acute Lymphoblastic Leukemia; TOWER Study to be presented at Presidential Symposium as a Best Abstract; sub-group analyses from pivotal head-to-head phase 3 studies provide further insight Into Kyprolis® (carfilzomib) as treatment option for patients With Multiple Myeloma; Aranesp® (darbepoetin alfa) phase 3 ARCADE data demonstrates significant reduction in red blood cell transfusions in anemic patients With Myelodysplastic Syndrome.

Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549, At Upcoming EHA And ASCO Meetings

5/20/2016 11:04 am

(Yahoo! Finance) May 19, 2016 - Preliminary data from CONTEMPO, a phase 1b/2 combination study evaluating duvelisib in treatment-naïve patients with follicular lymphoma, to be presented at EHA.

Researcher Under Fire For New Yorker Epigenetics Article

5/10/2016 11:04 am

(Nature.com) May 9, 2016 - Scientists attack Siddhartha Mukherjee’s feature exploring gene regulation.

New Treatment for Rare White Blood Cell Cancer

4/29/2016 11:01 am

(EMA) Apr 29, 2016 - The European Medicines Agency (EMA) has recommended extending the authorised indication of Gazyvaro (obinutuzumab) to treat patients with follicular lymphoma. The medicine is to be used in combination with bendamustine in patients who were previously treated with chemotherapy.

U.S. Biotechnologist Robert Langer Named European Inventor Award 2016 Finalist

4/27/2016 12:01 pm

(PRWEB) Apr 26, 2016 - The European Patent Office (EPO) today announced that M.I.T. Professor Robert Langer has been named as one of three finalists for the European Inventor Award 2016 in the category “Non-European countries.”

How Medicare Penalizes Hospitals for Being Too Careful

4/20/2016 12:03 pm

(New York Times/Kaiser Health News) Apr 20, 2016 - High rates of infections and other complications are prompting lower payments from Medicare, as well as protests from some elite hospitals.

Technology Supports Care for Patients Demanding More of Their Healthcare

4/20/2016 12:02 pm

(AJMC) Apr 19, 2016 - With patients increasingly demanding more of anyone involved in their healthcare, technology is playing an important role, explained panelists at a session of Specialty Pharmacy Connect, a pre-meeting program held ahead of the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016.

More People Seek Genetic Testing, But There Aren't Enough Counselors

4/19/2016 02:01 pm

(NPR/Shots blog) Apr 18, 2016 - The number of genetic counselors, the people who help both doctors and patients make sense of these tests, hasn't expanded enough to keep up with that demand.

Watercress Extract Detoxifies Carcinogens In Smokers, Clinical Trial Demonstrates

4/19/2016 01:05 pm

(UPMC) Apr 19, 2016 - Taken multiple times a day, watercress extract significantly inhibits carcinogen activity in smokers, a Pitt clinical trial showed.

Indian-American Scientist Creates T-Cells To Treat Pancreatic Cancer

4/19/2016 01:04 pm

(The Times of India/IANS) Apr 19, 2016 - An Indian-American scientist has engineered T-cells - a type of immune cells - to break the pancreatic cancer's physical and immunological walls using immunotherapy.

Gilead Bolsters Liver Disease Pipeline with Nimbus Drug Purchase

4/5/2016 11:02 am

(TheStreet) Apr 4, 2016 - Gilead Sciences is paying $400 million upfront to acquire an early-stage pipeline of liver disease drugs from privately held Nimbus Therapeutics, the companies announced Monday.

Immune-stimulating Drug, with Chemo, Shrinks Pancreas Tumors

4/5/2016 11:01 am

(URMC) Apr 4, 2016 - The results of an early-stage (phase 1b) clinical trial for pancreatic cancer show that an experimental therapy can control tumors well enough to make some patients eligible for surgery, according to data published in The Lancet Oncology by a Wilmot Cancer Institute investigator.

Highmark Cancer Collaborative Launches In Pennsylvania

3/31/2016 11:03 am

(Highmark) Mar 30, 2016 - Highmark Inc, an independent licensee of the Blue Cross and Blue Shield Association, today announced its new Highmark Cancer Collaborative.

UH Cancer Researchers Receive $3M From U.S. Defense Department

3/31/2016 11:03 am

(Pacific Business News) Mar 30, 2016 - Researchers at the University of Hawaii Cancer Center and John A. Burns School of Medicine in Honolulu have been awarded $3 million by the Department of Defense for mesothelioma-related research projects.

Penn Studies Show High Out-of Pocket Costs Limits Access to Lifesaving Specialty Drugs

3/29/2016 11:02 am

(Penn Medicine) Mar 29, 2016 - Insurers increasingly require patients to share the high costs of specialty drugs. Two new studies led by researchers at the Perelman School of Medicine at the University of Pennsylvania have found evidence that such cost-sharing arrangements are associated with significant reductions in access to these medications.